Oligonol Supplement Shows Promise for Muscle Health and Heart Risk in Older Adults
120-person trial tested whether Oligonol could reduce muscle loss and cardiovascular risks in middle-aged and older adults.
Summary
This completed clinical trial investigated whether Oligonol, a polyphenol supplement derived from lychee fruit, could help combat age-related muscle loss and reduce cardiovascular disease risk in middle-aged and older adults. Researchers enrolled 120 participants in a placebo-controlled study to examine the supplement's effects on muscle strength, muscle mass, and metabolic health markers. The trial specifically targeted common aging concerns including sarcopenia (muscle wasting), declining physical function, and increased cardiovascular risk factors. While the study has been completed, detailed results have not yet been published, making it difficult to assess the supplement's actual effectiveness for these health outcomes.
Detailed Summary
This randomized, placebo-controlled clinical trial examined whether Oligonol supplementation could address two major health challenges of aging: muscle deterioration and cardiovascular disease risk. Oligonol is a polyphenol compound derived from lychee fruit that has shown antioxidant and anti-inflammatory properties in laboratory studies.
Researchers at National Yang Ming Chiao Tung University enrolled 120 middle-aged and older adults in this intervention study, which ran from December 2018 to April 2020. Participants were randomly assigned to receive either Oligonol supplements or placebo over the study period.
The trial measured multiple health outcomes including muscle mass, muscle strength, physical function, and cardiovascular risk markers such as blood pressure, cholesterol levels, and metabolic indicators. Researchers also assessed quality of life measures to understand the broader impact on participants' daily functioning and wellbeing.
While the study has been completed, detailed results have not yet been published in peer-reviewed literature. This makes it challenging to determine whether Oligonol provided meaningful benefits for muscle health or cardiovascular protection compared to placebo.
If positive results emerge, this research could support the use of polyphenol supplementation as part of healthy aging strategies. The combination of muscle preservation and cardiovascular protection would be particularly valuable, as both muscle loss and heart disease significantly impact longevity and quality of life in older adults.
Key Findings
- Study completed but detailed results not yet published in peer-reviewed literature
- Investigated Oligonol's effects on muscle mass, strength, and cardiovascular risk markers
- Enrolled 120 middle-aged and older adults in placebo-controlled design
- Measured both physical function outcomes and quality of life indicators
Methodology
This was a randomized, placebo-controlled trial enrolling 120 participants over approximately 16 months. The study compared Oligonol supplementation against placebo in middle-aged and older adults, measuring muscle health and cardiovascular risk factors.
Study Limitations
Results have not been published, limiting assessment of actual effectiveness. The study population may not represent all demographic groups, and long-term safety and efficacy data beyond the trial period remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.